West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference
West Pharmaceutical Services (NYSE: WST), a leader in injectable drug administration solutions, has announced its participation in the upcoming CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST), a leader in injectable drug administration solutions, has announced its participation in the upcoming CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference. The company will be represented by Cindy Reiss-Clark (Sr. VP and Chief Commercial Officer), Chad Winters (VP of Finance and Chief Accounting Officer), and John Sweeney (VP of Investor Relations).
The presentation is scheduled for January 14, 2025, at 10:15 a.m. ET. Investors and interested parties can access the live audio webcast through the Investors section of West Pharmaceutical's website at www.westpharma.com.
Details
News Market Reaction – WST
The recorded move for WST in the trading session of this news was -0.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast will be available via the Investors section of our website, www.westpharma.com.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-pharmaceutical-services-to-present-at-the-cjs-25th-annual-new-ideas-for-the-new-year-investor-conference-302343236.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.